Emmanuel J Favaloro/LinkedIn
Sep 24, 2025, 17:17
Emmanuel J Favaloro: Proud to Be Part of This Esteemed Group
Emmanuel J Favaloro, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared a proud post on LinkedIn:
”Proud to be part of this esteemed group.
Ably led by my colleague, Bingwen Eugene Fan, “Sustainable anticoagulation for climate resilient care”.
Free to download for the next 50 days using this link.
Article: Sustainable anticoagulation for climate resilient care
Authors: Bingwen Eugene Fan, Kevin Milla, Scott McAlister, Brandon Jin An Ong, Sam Schulman, Roopen Arya, Helen Okoye, Suely Meireles Rezende, Giuseppe Lippi, Leonardo Pasalic, Bian Hong Wang, Ming Sheng Lim, Yen Lin Chee, Amanda Zain, Jeannie Su Hui Tey, Emmanuel J Favaloro
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
Amanda Zain
Anticoagulation
Bian Hong Wang
Bingwen Eugene Fan
Brandon Jin An Ong
climate resilient care
Emmanuel J Favaloro
Giuseppe Lippi
Health
Helen Okoye
Hematology
Hemostasis
Hemostasis Today
Jeannie Su Hui Tey
Kevin Milla
Leonardo Pasalic
Medicine
Ming Sheng Lim
Roopen Arya
Sam Schulman
Scott McAlister
Suely Meireles Rezende
thrombosis
Yen Lin Chee
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals
Sep 29, 2025, 12:54
Sep 29, 2025, 12:33
Sep 29, 2025, 06:23
Sep 29, 2025, 05:06
Sep 29, 2025, 04:28